STAT‐3 contributes to pulmonary fibrosis through epithelial injury and fibroblast‐myofibroblast differentiation-Reference-Cited by-同舟云学术

STAT‐3 contributes to pulmonary fibrosis through epithelial injury and fibroblast‐myofibroblast differentiation

Published:2015-08-31 Issue:1 Volume:30 Page:129-140
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Pedroza Mesias¹,Le Thuy T.²,Lewis Katherine³,Karmouty‐Quintana Harry²,To Sarah¹,George Anuh T.¹,Blackburn Michael R.²,Tweardy David J.³,Agarwal Sandeep K.¹

Affiliation:

1. Department of MedicineBaylor College of MedicineHoustonTexasUSA

2. Department of Biochemistry and Molecular BiologyUniversity of Texas Health Science Center, Houston Medical SchoolHoustonTexasUSA

3. Department of Infectious DiseaseBaylor College of MedicineHoustonTexasUSA

Funder

U.S. Department of Defense

National Institutes of Health

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.15-273953

Reference67 articles.

1. Clinical deterioration in patients with idiopathic pulmonary fibrosis: Causes and assessment

2. Incidence, Prevalence, and Clinical Course of Idiopathic Pulmonary Fibrosis

3. The burden of idiopathic pulmonary fibrosis: An unmet public health need

4. The epidemiology of interstitial lung diseases.

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STATs, promising targets for the treatment of autoimmune and inflammatory diseases;European Journal of Medicinal Chemistry;2024-11

2. Protective effect of rupatadine on testicular ischemia/reperfusion injury in rats: Modulation of IL-6/STAT3, Akt/ mTOR signaling pathways;Toxicology and Applied Pharmacology;2024-11

3. Licoricesaponin G2 ameliorates bleomycin-induced pulmonary fibrosis via targeting TNF-α signaling pathway and inhibiting the epithelial-mesenchymal transition;Frontiers in Pharmacology;2024-09-05

4. Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF);Expert Review of Clinical Pharmacology;2024-08-27

5. Bicyclol attenuates pulmonary fibrosis with silicosis via both canonical and non-canonical TGF-β1 signaling pathways;Journal of Translational Medicine;2024-07-26